Neuphoria Therapeutics Inc.
NEUP
$4.95
-$0.11-2.17%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
3/3/2025
-
GuruFocus
3/3/2025
-
Globe Newswire
2/15/2025
-
GuruFocus
2/15/2025
-
GuruFocus
2/12/2025
-
Seeking Alpha - Healthcare
2/12/2025
-
TipRanks Financial Blog
2/12/2025
-
The Fly
2/12/2025
-
GuruFocus
2/12/2025
-
GuruFocus
2/12/2025
-
Globe Newswire
2/12/2025
-
Tickeron - Technical Analysis
2/12/2025
-
Tickeron - Technical Analysis
2/6/2025
-
Zacks Investment Research
2/4/2025
-
TipRanks Financial Blog
1/25/2025
-
Insider Monkey
12/23/2024
-
Globe Newswire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, February 14, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Mar 10 and 14 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781-730-6665
Address
100 Summit Dr
Burlington, MA 01803
Burlington, MA 01803
Country
Year Founded
Business Description
Sector
Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in...
more
